Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenji So

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
ACG Case Reports Journal|September 8, 2017
Gastroduodenal Artery Psuedoaneurysm Bleed through a Spontaneous Pancreaticoduodenal Fistula as a Result of Acute Necrotizing PancreatitisSherman Picardo, Kenji So, Suresh Navadgi
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|June 10, 2020
Anti-TNF-induced lupus in patients with inflammatory bowel diseaseSherman Picardo, Kenji So, Kannan Venugopal
BMJ Case Reports|December 29, 2020
Infliximab-induced optic neuritisAndrew Dermawan, Kenji So, Kannan Venugopal, et al.
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|June 27, 2024
Analysis of Magnetic Resonance Imaging in Paranasal Mucocele with Visual DisturbanceHaruo Yoshida, Fujinobu Tanaka, Kenji So, et al.
BMJ Case Reports|January 7, 2018
Vedolizumab-induced acute pancreatitis: the first reported clinical caseSherman Picardo, Kenji So, Kannan Venugopal, et al.
Journal of Crohn'S & Colitis|July 25, 2012
Suppurative granulomatous inflammation in the ileo-anal pouchKenji So, Neil A Shepherd, Trupti Mandalia, et al.
Clinical Nutrition ESPEN|June 21, 2023
Peripheral parenteral nutrition: An evaluation of its use, safety and cost implications in a tertiary hospital settingAnisah Inayat-Hussain, Heather Falck, Sarah Oorschot, et al.
Annals of Gastroenterology|July 3, 2023
Combination therapy is not associated with improved rates of clinical or endoscopic remission in patients with inflammatory bowel disease treated with ustekinumab or vedolizumab: a retrospective studyAngus W Jeffrey, Sherman Picardo, Shankar Menon, et al.
Therapeutic Advances in Gastrointestinal Endoscopy|August 22, 2025
A pilot evaluation of the artificial intelligence system CAD-EYE to optically characterise lesions in inflammatory bowel disease surveillanceSherman Picardo, Shankar Menon, Kenji So, et al.
Annals of Clinical Biochemistry|March 18, 2015
Infliximab and adalimumab are stable in whole blood clotted samples for seven days at room temperatureMandy Perry, Claire Bewshea, Richard Brown, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
ACG Case Reports Journal|September 8, 2017
Gastroduodenal Artery Psuedoaneurysm Bleed through a Spontaneous Pancreaticoduodenal Fistula as a Result of Acute Necrotizing PancreatitisSherman Picardo, Kenji So, Suresh Navadgi
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|June 10, 2020
Anti-TNF-induced lupus in patients with inflammatory bowel diseaseSherman Picardo, Kenji So, Kannan Venugopal
BMJ Case Reports|December 29, 2020
Infliximab-induced optic neuritisAndrew Dermawan, Kenji So, Kannan Venugopal, et al.
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|June 27, 2024
Analysis of Magnetic Resonance Imaging in Paranasal Mucocele with Visual DisturbanceHaruo Yoshida, Fujinobu Tanaka, Kenji So, et al.
BMJ Case Reports|January 7, 2018
Vedolizumab-induced acute pancreatitis: the first reported clinical caseSherman Picardo, Kenji So, Kannan Venugopal, et al.
Journal of Crohn'S & Colitis|July 25, 2012
Suppurative granulomatous inflammation in the ileo-anal pouchKenji So, Neil A Shepherd, Trupti Mandalia, et al.
Clinical Nutrition ESPEN|June 21, 2023
Peripheral parenteral nutrition: An evaluation of its use, safety and cost implications in a tertiary hospital settingAnisah Inayat-Hussain, Heather Falck, Sarah Oorschot, et al.
Annals of Gastroenterology|July 3, 2023
Combination therapy is not associated with improved rates of clinical or endoscopic remission in patients with inflammatory bowel disease treated with ustekinumab or vedolizumab: a retrospective studyAngus W Jeffrey, Sherman Picardo, Shankar Menon, et al.
Therapeutic Advances in Gastrointestinal Endoscopy|August 22, 2025
A pilot evaluation of the artificial intelligence system CAD-EYE to optically characterise lesions in inflammatory bowel disease surveillanceSherman Picardo, Shankar Menon, Kenji So, et al.
Annals of Clinical Biochemistry|March 18, 2015
Infliximab and adalimumab are stable in whole blood clotted samples for seven days at room temperatureMandy Perry, Claire Bewshea, Richard Brown, et al.
Pageof 2